A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies

BACKGROUND: With increased use of antibiotics in high-risk patients, the investigation of new antibiotics to cover potentially resistant pathogens is warranted. In this prospective randomized trial, we compared ceftolozane/tazobactam (C/T), a new cephalosporin/β-lactamase inhibitor, to the standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaftari, Anne-Marie, Hachem, Ray, Malek, Alexandre E, Mulanovich, Victor E, Szvalb, Ariel D, Jiang, Ying, Yuan, Ying, Ali, Shahnoor, Deeba, Rita, Chaftari, Patrick, Raad, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154317/
https://www.ncbi.nlm.nih.gov/pubmed/35663286
http://dx.doi.org/10.1093/ofid/ofac079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154317/
https://www.ncbi.nlm.nih.gov/pubmed/35663286
http://dx.doi.org/10.1093/ofid/ofac079

Ejemplares similares